Latest News and Press Releases

WOBURN, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of...

Year-over-year improvements in gross profit, Adjusted EBITDA1 and net earnings. Closing backlog1 of $13.0 billion and reaffirmed 2026 guidance. WINNIPEG, Manitoba, May 07, 2026 (GLOBE NEWSWIRE) --...

Scripps reports Q1 2026 financial results

WOODBURY, N.Y., May 07, 2026 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its first quarter of 2026. Management will host a conference call today at...

MINNEAPOLIS, May 07, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it...

COPENHAGEN, Denmark, May 7, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, provides business...

Delivers Another Record Quarter and Reaffirms Full Year 2026 Guidance First Quarter 2026 Highlights1 Revenues of $385.2 million (8.6% growth year-over-year)Net income of $2.2 million (0.6% margin);...

Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026.

(All amounts are expressed in US dollars, tabular amounts in millions, unless otherwise stated) Fortuna generates record quarterly free cash flow1 of $174.0 million and adjusted attributable net...

LAVAL, Québec, May 06, 2026 (GLOBE NEWSWIRE) -- Savaria Corporation (“Savaria”) (TSX: SIS), one of the global leaders in the accessibility industry, is pleased to announce its results for...